Company Filing History:
Years Active: 2013
Title: Haiming Geng: Innovator in Antitumor and Antibacterial Agents
Introduction
Haiming Geng is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor and antibacterial properties. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Haiming Geng holds a patent for "5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same." This patent describes a method for preparing 5,6-dimethylxanthone-4-acetic acid (DMXAA) and its derivatives. The derivatives are represented by a specific formula, wherein R represents one to two substitutes at various positions selected from a range of chemical groups. The invention also includes a pharmaceutical composition that utilizes these derivatives as effective antitumor and antibacterial agents. Geng's patent is a testament to his innovative approach in addressing critical health challenges.
Career Highlights
Haiming Geng is associated with Grand Pharma (China) Co., Ltd., where he continues to contribute to pharmaceutical research and development. His work is characterized by a commitment to creating effective treatments that can improve patient outcomes. Geng's innovative spirit and scientific acumen have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Haiming Geng has collaborated with notable colleagues such as Wei Li and Guofan Xie. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in their field.
Conclusion
Haiming Geng's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the development of antitumor and antibacterial agents. His work continues to inspire advancements in medical science and improve health outcomes for patients.